These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20394377)

  • 1. Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor.
    Calleri E; Ceruti S; Cristalli G; Martini C; Temporini C; Parravicini C; Volpini R; Daniele S; Caccialanza G; Lecca D; Lambertucci C; Trincavelli ML; Marucci G; Wainer IW; Ranghino G; Fantucci P; Abbracchio MP; Massolini G
    J Med Chem; 2010 May; 53(9):3489-501. PubMed ID: 20394377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an immobilized GPR17 receptor stationary phase for binding determination using frontal affinity chromatography coupled to mass spectrometry.
    Temporini C; Ceruti S; Calleri E; Ferrario S; Moaddel R; Abbracchio MP; Massolini G
    Anal Biochem; 2009 Jan; 384(1):123-9. PubMed ID: 18835238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Ability of New Ligands for G Protein-Coupled Receptors 17 (GPR17).
    Zhuo T; Zhou S; Zhang W; Lambertucci C; Volpini R
    Med Sci Monit; 2017 Feb; 23():953-959. PubMed ID: 28223679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor.
    Ciana P; Fumagalli M; Trincavelli ML; Verderio C; Rosa P; Lecca D; Ferrario S; Parravicini C; Capra V; Gelosa P; Guerrini U; Belcredito S; Cimino M; Sironi L; Tremoli E; Rovati GE; Martini C; Abbracchio MP
    EMBO J; 2006 Oct; 25(19):4615-27. PubMed ID: 16990797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR17: molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors.
    Parravicini C; Ranghino G; Abbracchio MP; Fantucci P
    BMC Bioinformatics; 2008 Jun; 9():263. PubMed ID: 18533035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forced unbinding of GPR17 ligands from wild type and R255I mutant receptor models through a computational approach.
    Parravicini C; Abbracchio MP; Fantucci P; Ranghino G
    BMC Struct Biol; 2010 Mar; 10():8. PubMed ID: 20233425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of two isoforms of the P2Y-like receptor GPR17: [35S]GTPgammaS binding and electrophysiological studies in 1321N1 cells.
    Pugliese AM; Trincavelli ML; Lecca D; Coppi E; Fumagalli M; Ferrario S; Failli P; Daniele S; Martini C; Pedata F; Abbracchio MP
    Am J Physiol Cell Physiol; 2009 Oct; 297(4):C1028-40. PubMed ID: 19625605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Orphan Receptor GPR17 Is Unresponsive to Uracil Nucleotides and Cysteinyl Leukotrienes.
    Simon K; Merten N; Schröder R; Hennen S; Preis P; Schmitt NK; Peters L; Schrage R; Vermeiren C; Gillard M; Mohr K; Gomeza J; Kostenis E
    Mol Pharmacol; 2017 May; 91(5):518-532. PubMed ID: 28254957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases.
    Eberini I; Daniele S; Parravicini C; Sensi C; Trincavelli ML; Martini C; Abbracchio MP
    J Comput Aided Mol Des; 2011 Aug; 25(8):743-52. PubMed ID: 21744154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A promiscuous recognition mechanism between GPR17 and SDF-1: Molecular insights.
    Parravicini C; Daniele S; Palazzolo L; Trincavelli ML; Martini C; Zaratin P; Primi R; Coppolino G; Gianazza E; Abbracchio MP; Eberini I
    Cell Signal; 2016 Jun; 28(6):631-42. PubMed ID: 26971834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist-induced desensitization/resensitization of human G protein-coupled receptor 17: a functional cross-talk between purinergic and cysteinyl-leukotriene ligands.
    Daniele S; Trincavelli ML; Gabelloni P; Lecca D; Rosa P; Abbracchio MP; Martini C
    J Pharmacol Exp Ther; 2011 Aug; 338(2):559-67. PubMed ID: 21531793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is GPR17 a P2Y/leukotriene receptor? examination of uracil nucleotides, nucleotide sugars, and cysteinyl leukotrienes as agonists of GPR17.
    Qi AD; Harden TK; Nicholas RA
    J Pharmacol Exp Ther; 2013 Oct; 347(1):38-46. PubMed ID: 23908386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The G Protein-Coupled Receptor GPR17: Overview and Update.
    Marucci G; Dal Ben D; Lambertucci C; Santinelli C; Spinaci A; Thomas A; Volpini R; Buccioni M
    ChemMedChem; 2016 Dec; 11(23):2567-2574. PubMed ID: 27863043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair.
    Lecca D; Trincavelli ML; Gelosa P; Sironi L; Ciana P; Fumagalli M; Villa G; Verderio C; Grumelli C; Guerrini U; Tremoli E; Rosa P; Cuboni S; Martini C; Buffo A; Cimino M; Abbracchio MP
    PLoS One; 2008; 3(10):e3579. PubMed ID: 18974869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of PC12 cell survival and differentiation by the new P2Y-like receptor GPR17.
    Daniele S; Lecca D; Trincavelli ML; Ciampi O; Abbracchio MP; Martini C
    Cell Signal; 2010 Apr; 22(4):697-706. PubMed ID: 20056144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modeling and dynamics studies of the synthetic small molecule agonists with GPR17 and P2Y1 receptor.
    Murugesan A; Nguyen P; Ramesh T; Yli-Harja O; Kandhavelu M; Saravanan KM
    J Biomol Struct Dyn; 2022; 40(23):12908-12916. PubMed ID: 34542380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury.
    Ceruti S; Villa G; Genovese T; Mazzon E; Longhi R; Rosa P; Bramanti P; Cuzzocrea S; Abbracchio MP
    Brain; 2009 Aug; 132(Pt 8):2206-18. PubMed ID: 19528093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPR17 receptor modulators and their therapeutic implications: review of recent patents.
    Marucci G; Dal Ben D; Lambertucci C; Martí Navia A; Spinaci A; Volpini R; Buccioni M
    Expert Opin Ther Pat; 2019 Feb; 29(2):85-95. PubMed ID: 30640576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new P2Y-like receptor G protein-coupled receptor 17 mediates acute neuronal injury and late microgliosis after focal cerebral ischemia in rats.
    Zhao B; Zhao CZ; Zhang XY; Huang XQ; Shi WZ; Fang SH; Lu YB; Zhang WP; Xia Q; Wei EQ
    Neuroscience; 2012 Jan; 202():42-57. PubMed ID: 22155652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of dual nucleotides/cysteinyl-leukotrienes receptor GPR17 in early trafficking of cardiac stromal cells after myocardial infarction.
    Cosentino S; Castiglioni L; Colazzo F; Nobili E; Tremoli E; Rosa P; Abbracchio MP; Sironi L; Pesce M
    J Cell Mol Med; 2014 Sep; 18(9):1785-96. PubMed ID: 24909956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.